← Back to Clinical Trials
Recruiting NCT06424743

NCT06424743 Preference of Women With Fibromyalgia Undergoing a Three Different Volumes of Resistance Training

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06424743
Status Recruiting
Phase
Sponsor Universidade Federal do Rio Grande do Norte
Condition Fibromyalgia, Primary
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2025-07-01
Primary Completion 2026-09-01

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 36 participants in total. It began in 2025-07-01 with a primary completion date of 2026-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Fibromyalgia is a painful syndrome of unknown etiology, which affects 2% of world population, with symptoms such as: pain, unrefreshing sleep, fatigue and mood disorders. It is already established in the literature that resistance training is part of the non- pharmacological treatment for patients with fibromyalgia. The big gap is about the quantity adequate and/or recommended exercise volume, despite some studies with exercise volumes different resistance trainings show improvements, we do not have a direction, besides We still do not know whether there is a preference for these patients in different resistance training volumes.

Eligibility Criteria

Inclusion Criteria: * Women aged 18 to 65 * Have a diagnosis of fibromyalgia according to the ACR 2016 criteria Exclusion Criteria: * Have performed resistance training in the last 6 months * Having another associated rheumatic condition * Have a trip or appointment scheduled that requires absence for the next 4 (four) weeks from the start of the survey; * Women with musculoskeletal injuries in the upper and/or lower limbs * Have heart problems that prevent maximal efforts and submaximums

Contact & Investigator

Central Contact

Marcelo C de Souza, PT, PhD

✉ marcelo.cardoso@ufrn.br

📞 55849994806892

Frequently Asked Questions

Who can join the NCT06424743 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Fibromyalgia, Primary. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06424743 currently recruiting?

Yes, NCT06424743 is actively recruiting participants. Contact the research team at marcelo.cardoso@ufrn.br for enrollment information.

Where is the NCT06424743 trial being conducted?

This trial is being conducted at Natal, Brazil.

Who is sponsoring the NCT06424743 clinical trial?

NCT06424743 is sponsored by Universidade Federal do Rio Grande do Norte. The trial plans to enroll 36 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology